ISoP European Chapter offers new opportunities for connection among members

Communications / 28 June 2023

As well as promoting PV research and training in Europe, the chapter aims to foster communication and collaboration between European institutions working in drug safety.


The European chapter of ISoP was launched at the mid-year meeting of the International Society of Pharmacovigilance (ISoP), held in Leiden (NL) on 1-2 June 2023. This chapter was born from the initiative of several ISoP members who work at European pharmacovigilance research institutions.

The purpose of this chapter is to implement ISoP activities related to scientific research and training in Europe, especially in European countries that have a strong tradition of pharmacovigilance activities but are poorly represented in ISoP. The European chapter will also support the dialogue between ISoP and international institutions based in Europe that work in drug safety research and management (e.g., EMA, WHO, UMC, and CIOMS), as well as European research networks such as ENCePP.

At the first assembly of the chapter, proposals for the development of future activities were discussed, such as the organisation of official ISoP events (annual meetings, mid-year meetings), specific European events dedicated to pharmacovigilance research and training webinars. The ISoP European chapter should function as the platform for the exchange of ideas and information that can lead to collaborations between various member centres. In terms of training, the establishment of a student exchange program between these institutions was proposed, based on the model of the ERASMUS project. Depending on specific needs, we also envisage the creation of expert groups, extended to all ISoP members, who can produce documents and scientific articles on major themes in pharmacovigilance.

The chapter is currently coordinated by Marco Tuccori (Italy) (marco.tuccori@gmail.com), Gianluca Trifirò (Italy) (gianluca.trifiro@univr.it), Linda Harmark (Netherlands) (l.harmark@lareb.nl), and Felipe Villalobos Martinez (Spain) (fvillalobos@idiapjgol.info).

Read More:

ISoP European chapter webpage

Pharmacovigilance, where science meets practice, Uppsala Reports

Marco Tuccori
Pharmacovigilance Manager, Unit of Adverse Drug Reactions Monitoring University Hospital of Pisa, Italy

You may also like


Patient voices in pharmacovigilance takes centre stage at ISoP Bali 2023

The most recent ISoP event saw hundreds of experts gather to explore the latest innovations and challenges facing pharmacovigilance, with a special focus on patient perspectives.

Communications / 16 January 2024

When drugs damage the liver– New podcast out now

The liver, responsible for drug metabolism in the body, is also most at risk of damage due to medicines. Unravel the complexities of DILI and its impact on medication safety.

Communications / 05 February 2024

Patient safety set to gain from new partnership between CDISC and UMC

The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

Communications / 20 February 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more